Exploring the Psycological Effects of Formoterol Fumarate and Budesonide Inhaler: A Case Study on Induced Depression
Abstract
A patient with a longstanding history of chronic obstructive pulmonary disease (COPD) presented with significant weight loss, loss of appetite, fatigue, and sleep disturbance persisting for 15 days, alongside a rapid weight loss of 15 kg in 10 days. Initial evaluations revealed bilateral pleural effusion, complicating her clinical picture. Despite no prior psychiatric history, a psychiatric evaluation indicated severe sleep disturbances, reduced food intake, and pronounced fatigue, leading to a diagnosis of depression. The patient's regular treatment included an inhaler containing formoterol fumarate and budesonide for 35 years. Notably, the inhaler’s long-term use may have contributed to her depressive symptoms. Emergency treatment involved intravenous administration of normal saline with multivitamins, pantoprazole to manage potential gastrointestinal complications, and a multivitamin and multimineral syrup. Psychiatric management included sertraline, an SSRI, to ameliorate depressive symptoms and zolpidem for sleep disturbances. This multidisciplinary approach resulted in significant improvement. Upon discharge, the patient was stable and prescribed a regimen including sertraline, pantoprazole, mirtazapine, zolpidem, and multivitamins to support her long-term recovery and well-being. The case underscores the potential for inhaler-induced depression in patients with COPD and the importance of a comprehensive treatment plan.
Keywords: Depression, Adverse event of inhaled drugs, chronic obstructive pulmonary disease, Weight loss
Keywords:
Depression , COPD, weightloss, adverse event of inhaler drugDOI
https://doi.org/10.22270/jddt.v14i12.6918References
1. Vikjord SAA, Brumpton BM, Mai XM, Vanfleteren L, Langhammer A. The association of anxiety and depression with mortality in a COPD cohort. The HUNT study, Norway. Respir Med. 2020;171:106089. https://doi.org/10.1016/j.rmed.2020.106089 PMid:32799059
2. Wilson I. Depression in the patient with COPD. Int J Chron Obstruct Pulmon Dis. 2006;1(1):61-64. https://doi.org/10.2147/copd.2006.1.1.61 PMid:18046903 PMCid:PMC2706604
3. Rahi MS, Thilagar B, Balaji S, Prabhakaran SY, Mudgal M, Rajoo S, Yella PR, Satija P, Zagorulko A, Gunasekaran K. The Impact of Anxiety and Depression in Chronic Obstructive Pulmonary Disease. Advances in Respiratory Medicine. 2023; 91(2):123-134. https://doi.org/10.3390/arm91020011 PMid:36960961 PMCid:PMC10037643
4. Turégano-Yedro M, Trillo-Calvo E, Navarro I Ros F, et al. Inhaler Adherence in COPD: A Crucial Step Towards the Correct Treatment. Int J Chron Obstruct Pulmon Dis. 2023;18:2887-2893. https://doi.org/10.2147/COPD.S431829 PMid:38059011 PMCid:PMC10697822
5. Yohannes AM, Kaplan A, Hanania NA. Anxiety and Depression in Chronic Obstructive Pulmonary Disease: Recognition and Management. Cleve Clin J Med. 2018;85(2 Suppl 1):S11-S18. https://doi.org/10.3949/ccjm.85.s1.03 PMid:29494328
Published
Abstract Display: 550
PDF Downloads: 499
PDF Downloads: 65 How to Cite
Issue
Section
Copyright (c) 2024 Subashini R, Priyadharshini R, Aishwarya S, Hema V

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

.